The Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Drugs market size is expected to reach $35.71 billion in 2030 at a CAGR of 19.4%, driven by increasing investment in breast cancer R&D.
Read More
The C-X-C Chemokine Receptor Type 2 market size is expected to reach $2.39 billion in 2030 at a CAGR of 11.5%, driven by rising prevalence of inflammatory conditions.
Read More
The Custom Antibody market size is expected to reach $0.86 billion in 2030 at a CAGR of 12.8%, driven by growing demand for personalized medicine.
Read More
The CTLA4 Inhibitors market size is expected to reach $11.84 billion in 2030 at a CAGR of 16.0%, driven by rising incidence of cancer.
Read More
The Cryptococcosis Therapeutics market size is expected to reach $5.33 billion in 2030 at a CAGR of 5.2%, driven by rising HIV/AIDS prevalence.
Read More
The Cryogenic Vaporizer market size is expected to reach $6.89 billion in 2030 at a CAGR of 5.9%, driven by growing demand for natural gas.
Read More
The Crohn’s Disease Treatment market size is expected to reach $18.86 billion in 2030 at a CAGR of 7.8%, driven by increase in inflammatory bowel disorder prevalence.
Read More
The Critical Care Drugs market size is expected to reach $1.53 billion in 2030 at a CAGR of 6.1%, driven by rise in the number of surgical procedures.
Read More
The Critical Care Antiarrhythmic Drugs market size is expected to reach $1.39 billion in 2030 at a CAGR of 5.3%, driven by increasing prevalence of cardiovascular disease.
Read More
The COVID-19 Drug Associated APIs market size is expected to reach $9.69 billion in 2030 at a CAGR of 6.4%, driven by government initiatives in healthcare R&D.
Read More